SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028111
Filing Date
2018-11-07
Accepted
2018-11-07 17:07:18
Documents
50
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrca-10q_20180930.htm 10-Q 1838453
2 EX-10.1 vrca-ex101_117.htm EX-10.1 197842
3 EX-31.1 vrca-ex311_8.htm EX-31.1 15048
4 EX-31.2 vrca-ex312_7.htm EX-31.2 14983
5 EX-32.1 vrca-ex321_6.htm EX-32.1 11204
  Complete submission text file 0001564590-18-028111.txt   5792798

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vrca-20180930.xml EX-101.INS 1070159
7 XBRL TAXONOMY EXTENSION SCHEMA vrca-20180930.xsd EX-101.SCH 32916
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vrca-20180930_cal.xml EX-101.CAL 28946
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vrca-20180930_def.xml EX-101.DEF 189850
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20180930_lab.xml EX-101.LAB 284480
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20180930_pre.xml EX-101.PRE 260525
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38529 | Film No.: 181167268
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1